Mirabegron
Back to searchMolecule Structure
Scientific Name
Mirabegron
Description of the Drug
Mirabegron is a beta-3 adrenergic agonist used to treat overactive bladder and neurogenic detrusor overactivity.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08893
http://www.drugbank.ca/drugs/DB08893
Brand Name(s)
Betmiga, Myrbetriq, Myrbetriq granules
Company Owner(s)
Sawai Usa Inc, Astellas Pharma Global Development Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-3 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL246 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL904788 | |
| DrugBank | DB08893 | |
| PubChem: Thomson Pharma | 14830284 | 15100038 |
| PubChem | 9865528 | |
| Nikkaji | J1.648.518G | |
| PDBe | H6U | |
| DrugCentral | 4382 | |
| Guide to Pharmacology | 7445 | |
| rxnorm | MIRABEGRON | MYRBETRIQ |
| ChEBI | 65349 | |
| ZINC | ZINC000001996784 |
